Recensioni verificate Soddisfatta del servizio.
Personale disponibile e gentile. Lo consiglio a tutti ...
Cliente Sorgente Genetica
logomysorgente

02  4948  5291

  • Cos'è AURORA

    Aurora è il test di screening prenatale di ultima generazione 
    sicuro, affidabile,
    veloce e precoce

  • Sicuro

    Grazie a un semplice prelievo di sangue materno
    eviti il rischio di aborto di tecniche invasive come amniocentesi o villocentesi

  • Affidabile

    Oltre il 99,9% di affidabilità nel rilevare
    la trisomia 21, responsabile
    della Sindrome di Down

  • Precoce e veloce

    icona svegliaIndividuare precocemente la presenza di anomalie cromosomiche è fondamentale:
    puoi effettuare Aurora dalla 10ª settimana

    icona documentoIl test è veloce: risultati in 7-10 giorni lavorativi con la percentuale di test da ripetere più bassa del mercato: 0,1%

  • La serenità della mamma
    in 3 semplici passi

    icotelefona

    Prenota il test

    icoesami

    Fai un prelievo di sangue

    icoginecologo

    Leggi i risultati

  • Test diagnosi prenatale non invasivo
  • 151126 banner Aurora mobile 01
  • 151126 banner Aurora mobile 02
  • 151126 banner Aurora mobile 03
  • slide mobile03
cover cartoon
cover venturetti

Ultime notizie dal mondo della genetica


What are the genes of male breast cancer?

A team of Sapienza di Roma analyzed the genetic causes of male breast cancer. Given its low incidence, in fact, there are very few studies in this regard. The Italian scientists have instead focused on the genes that make Italian men more prone to cancer. The aim is to understand the basis of the genetic susceptibility of this form of cancer, so as to improve diagnosis and treatment.

The main breast cancer genes are BRCA1 and BRCA2. Scholars involved 523 men with breast cancer, of whom only 20 with BRCA mutations. In this way they focused on the other genes responsible for male mammary tumors. They analyzed 50 genes, all previously studied and largely heritable.

Mutations in the PALB2 gene are the most prevalent among men with breast cancer. Given their clear prevalence, researchers suspect that the gene could play a key role in the disease. The study of only Italian subjects has instead allowed us to better analyze our population genetics. In other countries the prevalent gene of male breast cancer is indeed another.

Usually the predominant gene in men with breast cancer is CHEK2. The mutations of this gene are however almost completely absent in Italy, which raises new questions. The next step will be to understand how the mutations of PALB2 increase the risk of cancer. In this way it will be possible to develop a specific breast screening for men.

Source: repubblica.it

Link social

Link social